Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert Goosmann who wrote (6642)	7/10/1998 10:13:00 PM
From: opalapril	Read Replies (1) \| Respond to of 17367

The tech vacancies must have been added this week because I checked last weekend and they weren't listed then. On the other hand we don't know if these are old or new positions. Xoma has been manufacturing rBPI all along for the P-3 trial, hasn't it? How else get Neuprex to the clinical sites? I also think I read somewhere in re: another company that the FDA had to approve the manufacturing process or plant or something before any P-3 trial could get underway. What one needs to know is how many tech positions there were before and how many have been budgeted for the future.